Island Neurological Associates, PC

Plainview, New York 11803-4491

0 studies enrolling now · 12 studies all time

What they study most

Aura, Chronic Migraine, Episodic Migraine, Migraine, Migraine Disorders, Migraine Headache, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Neuralgia, Postherpetic

Studies at this site

• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
• Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults — Completed
• Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine — Completed
• Staccato Prochlorperazine in Migraine (Out Patient) — Completed
• Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis — Completed
• Calcitonin Gene-related Peptide Levels in Chronic Migraine — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed
• "Completeness of Response" Following Treatment With Treximet™ for Migraine — Completed